0000000000516069

AUTHOR

Félix Gutiérrez

0000-0002-9485-6867

showing 3 related works from this author

Análisis bibliométrico de la producción científica española en Enfermedades Infecciosas y en Microbiología.

2016

Resumen Introduccion El analisis bibliometrico de la produccion y repercusion de los documentos por areas de conocimiento es un indicador cuantitativo y cualitativo de la actividad investigadora realizada en ese campo. El objetivo de este articulo es conocer la contribucion de las instituciones espanolas a la investigacion en Enfermedades Infecciosas y en Microbiologia en los ultimos anos. Material y metodos Se analizaron los documentos publicados en las revistas incluidas en las categorias «Infectious Diseases» y «Microbiology» de la Web of Science (Science Citation Index Expanded) de la ISI Web of Knowledge desde el ano 2000 al 2013. Resultados En Enfermedades Infecciosas, Espana ocupo la…

0301 basic medicineMicrobiology (medical)03 medical and health sciences0302 clinical medicine030106 microbiology030212 general & internal medicineBibliometric analysis Enfermedades infecciosas España Estudio bibliométrico Infectious diseases Microbiology Microbiología Producción científica Scientific production Spain
researchProduct

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabin…

2019

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10 mg was investigated through 96 weeks in EMERALD (NCT02269917). Virologically-suppressed, HIV-1-positive treatment-experienced adults (previous non-darunavir virologic failure [VF] allowed) were randomized (2:1) to D/C/F/TAF or boosted protease inhibitor (PI) plus emtricitabine/tenofovir-disoproxil-fumarate (F/TDF) over 48 weeks. At week 52 participants in the boosted PI arm were offered switch to D/C/F/TAF (late-switch, 44 weeks D/C/F/TAF exposure). All participants were followed on D/C/F/TAF until week 96. Efficacy endpoints were percentage cumulative protocol-defined virologic rebound (PDVR; confirmed vira…

MaleDOLUTEGRAVIRSustained Virologic ResponseHIV InfectionsGastroenterologychemistry.chemical_compound0302 clinical medicineMedicine and Health SciencesEmtricitabine030212 general & internal medicinePharmacology & PharmacyDarunavir0303 health sciencesAlanineDrug SubstitutionCobicistatEmtricitabine Tenofovir Disoproxil Fumarate Drug CombinationLamivudineAntiretroviralsMiddle AgedViral LoadOPEN-LABEL3. Good healthWEIGHT-GAINDrug CombinationsTreatment OutcomeDolutegravirNON-INFERIORITYFemaleSafetyViral loadLife Sciences & Biomedicinemedicine.drugTabletsAdultmedicine.medical_specialtyEfficacyAnti-HIV AgentsRITONAVIREmtricitabineTENOFOVIR ALAFENAMIDELAMIVUDINETenofovir alafenamideSingle-tablet regimen03 medical and health sciencesInternal medicineVirologymedicineVIH (Virus)HumansSwitch studyProtease InhibitorsTenofovirDarunavirAgedPharmacologyScience & Technology030306 microbiologybusiness.industryHIV (Viruses)AdenineDarunavir/cobicistat/emtricitabine/TAFAntiretroviral agentsCOBICISTATMAINTENANCEchemistry[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHIV-1RitonavirCobicistat[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusinessRESISTANCE
researchProduct

Mapping of Chagas disease research: analysis of publications in the period between 1940 and 2009

2011

INTRODUCTION: Publications are often used as a measure of success in research work. Chagas disease occurs in Central and Southern America. However, during the past years, the disease has been occurring outside Latin America due to migration from endemic zones. This article describes a bibliometric review of the literature on Chagas disease research indexed in PubMed during a 70-year period. METHODS: Medline was used via the PubMed online service of the U.S. National Library of Medicine from 1940 to 2009. The search strategy was: Chagas disease [MeSH] OR Trypanosoma cruzi [MeSH]. RESULTS: A total of 13,989 references were retrieved. The number of publications increased steadily over time fro…

Microbiology (medical)Chagas diseaseChagas diseaselcsh:Arctic medicine. Tropical medicinelcsh:RC955-962Trypanosoma cruziBibliometryBiologyMapeamentoDoença de ChagasBibliometriaparasitic diseasesmedicineHumansChagas DiseaseProdução científicaResearchScientific productionmedicine.diseaseInfectious DiseasesMappingBibliometricsTripanossomíase AmericanaParasitologyAmericasPeriodicals as TopicHumanitiesScientific productionAmerican trypanosomiasisRevista da Sociedade Brasileira de Medicina Tropical
researchProduct